PharmaEssentia Corp. Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Burlington MA United States (2003)

Organization Overview

First Clinical Trial
2009
NCT05129644
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

PharmaEssentia | PharmaEssentia Corp. | PharmaEssentia Corporation | PharmaEssentia Corporation (Co-Sponsor for USA) | PharmaEssentia (Co-Sponsor for USA) | PharmaEssentia Japan K.K.